SOD1 and metabolic dysfunction-associated steatotic liver disease: In a study in which nonalcoholic fatty liver disease model was established in rats, it was reported that PNX‐14 decreased MDA level, increased SOD and GSH enzyme levels and reduced oxidative stress as a result [19].